Percutaneous sclerotherapy of lymphoceles related to renal transplantation

Berta M. Montalvo, Jose Yrizarry, Victor Casillas, George W Burke, Mustafa Allouch, Marco A. Amendola, Daniel Seckinger

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

PURPOSE: To determine the advantages of using transcatheter sclerotherapy to treat renal allograft-related lymphoceles. MATERIALS AND METHODS: Eighteen patients first seen with symptomatic lymphoceles secondary to renal transplantation were treated with povidone-iodine percutaneous sclerotherapy. Percutaneous catheters were placed by means of sonographic, computed tomographic, or combined fluoroscopic and sonographic guidance. Sclerotherapy was initiated while patients were in the hospital, and the patients then instilled povidone-iodine twice a day at home. RESULTS: One patient had an inadequate trial period of therapy and was not included in the analysis. Seventeen lymphoceles were adequately sclerosed. Average length of treatment was 35 days. Three lymphoceles recurred and were effectively treated percutaneously. Follow-up studies showed no recurrence 1 month to 2 years after completion of therapy. No patient needed surgery for lymphocele repair. CONCLUSION: Because of its safety and efficacy, percutaneous transcatheter sclerotherapy with povidone-iodine should be the treatment of choice in patients with lymphoceles that develop after renal transplantation.

Original languageEnglish
Pages (from-to)117-123
Number of pages7
JournalJournal of Vascular and Interventional Radiology
Volume7
Issue number1
StatePublished - Dec 1 1996

Fingerprint

Lymphocele
Sclerotherapy
Kidney Transplantation
Povidone-Iodine
Therapeutics
Allografts
Catheters
Kidney
Safety
Recurrence

Keywords

  • Kidney, transplantation, 81.455
  • Lymphatic system, interventional procedure, 99.126
  • Lymphocele, 81.4556

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Montalvo, B. M., Yrizarry, J., Casillas, V., Burke, G. W., Allouch, M., Amendola, M. A., & Seckinger, D. (1996). Percutaneous sclerotherapy of lymphoceles related to renal transplantation. Journal of Vascular and Interventional Radiology, 7(1), 117-123.

Percutaneous sclerotherapy of lymphoceles related to renal transplantation. / Montalvo, Berta M.; Yrizarry, Jose; Casillas, Victor; Burke, George W; Allouch, Mustafa; Amendola, Marco A.; Seckinger, Daniel.

In: Journal of Vascular and Interventional Radiology, Vol. 7, No. 1, 01.12.1996, p. 117-123.

Research output: Contribution to journalArticle

Montalvo, BM, Yrizarry, J, Casillas, V, Burke, GW, Allouch, M, Amendola, MA & Seckinger, D 1996, 'Percutaneous sclerotherapy of lymphoceles related to renal transplantation', Journal of Vascular and Interventional Radiology, vol. 7, no. 1, pp. 117-123.
Montalvo, Berta M. ; Yrizarry, Jose ; Casillas, Victor ; Burke, George W ; Allouch, Mustafa ; Amendola, Marco A. ; Seckinger, Daniel. / Percutaneous sclerotherapy of lymphoceles related to renal transplantation. In: Journal of Vascular and Interventional Radiology. 1996 ; Vol. 7, No. 1. pp. 117-123.
@article{a251387f410d47f28c70f896e365956f,
title = "Percutaneous sclerotherapy of lymphoceles related to renal transplantation",
abstract = "PURPOSE: To determine the advantages of using transcatheter sclerotherapy to treat renal allograft-related lymphoceles. MATERIALS AND METHODS: Eighteen patients first seen with symptomatic lymphoceles secondary to renal transplantation were treated with povidone-iodine percutaneous sclerotherapy. Percutaneous catheters were placed by means of sonographic, computed tomographic, or combined fluoroscopic and sonographic guidance. Sclerotherapy was initiated while patients were in the hospital, and the patients then instilled povidone-iodine twice a day at home. RESULTS: One patient had an inadequate trial period of therapy and was not included in the analysis. Seventeen lymphoceles were adequately sclerosed. Average length of treatment was 35 days. Three lymphoceles recurred and were effectively treated percutaneously. Follow-up studies showed no recurrence 1 month to 2 years after completion of therapy. No patient needed surgery for lymphocele repair. CONCLUSION: Because of its safety and efficacy, percutaneous transcatheter sclerotherapy with povidone-iodine should be the treatment of choice in patients with lymphoceles that develop after renal transplantation.",
keywords = "Kidney, transplantation, 81.455, Lymphatic system, interventional procedure, 99.126, Lymphocele, 81.4556",
author = "Montalvo, {Berta M.} and Jose Yrizarry and Victor Casillas and Burke, {George W} and Mustafa Allouch and Amendola, {Marco A.} and Daniel Seckinger",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "7",
pages = "117--123",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Percutaneous sclerotherapy of lymphoceles related to renal transplantation

AU - Montalvo, Berta M.

AU - Yrizarry, Jose

AU - Casillas, Victor

AU - Burke, George W

AU - Allouch, Mustafa

AU - Amendola, Marco A.

AU - Seckinger, Daniel

PY - 1996/12/1

Y1 - 1996/12/1

N2 - PURPOSE: To determine the advantages of using transcatheter sclerotherapy to treat renal allograft-related lymphoceles. MATERIALS AND METHODS: Eighteen patients first seen with symptomatic lymphoceles secondary to renal transplantation were treated with povidone-iodine percutaneous sclerotherapy. Percutaneous catheters were placed by means of sonographic, computed tomographic, or combined fluoroscopic and sonographic guidance. Sclerotherapy was initiated while patients were in the hospital, and the patients then instilled povidone-iodine twice a day at home. RESULTS: One patient had an inadequate trial period of therapy and was not included in the analysis. Seventeen lymphoceles were adequately sclerosed. Average length of treatment was 35 days. Three lymphoceles recurred and were effectively treated percutaneously. Follow-up studies showed no recurrence 1 month to 2 years after completion of therapy. No patient needed surgery for lymphocele repair. CONCLUSION: Because of its safety and efficacy, percutaneous transcatheter sclerotherapy with povidone-iodine should be the treatment of choice in patients with lymphoceles that develop after renal transplantation.

AB - PURPOSE: To determine the advantages of using transcatheter sclerotherapy to treat renal allograft-related lymphoceles. MATERIALS AND METHODS: Eighteen patients first seen with symptomatic lymphoceles secondary to renal transplantation were treated with povidone-iodine percutaneous sclerotherapy. Percutaneous catheters were placed by means of sonographic, computed tomographic, or combined fluoroscopic and sonographic guidance. Sclerotherapy was initiated while patients were in the hospital, and the patients then instilled povidone-iodine twice a day at home. RESULTS: One patient had an inadequate trial period of therapy and was not included in the analysis. Seventeen lymphoceles were adequately sclerosed. Average length of treatment was 35 days. Three lymphoceles recurred and were effectively treated percutaneously. Follow-up studies showed no recurrence 1 month to 2 years after completion of therapy. No patient needed surgery for lymphocele repair. CONCLUSION: Because of its safety and efficacy, percutaneous transcatheter sclerotherapy with povidone-iodine should be the treatment of choice in patients with lymphoceles that develop after renal transplantation.

KW - Kidney, transplantation, 81.455

KW - Lymphatic system, interventional procedure, 99.126

KW - Lymphocele, 81.4556

UR - http://www.scopus.com/inward/record.url?scp=0029688356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029688356&partnerID=8YFLogxK

M3 - Article

C2 - 8773985

AN - SCOPUS:0029688356

VL - 7

SP - 117

EP - 123

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 1

ER -